(ALB) Albemarle - Overview
Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: NYSE (USA) | Market Cap: 20.994m USD | Total Return: 190% in 12m
Industry Rotation: +9.2
Avg Turnover: 285M USD
Peers RS (IBD): 92.9
EPS Trend: -83.1%
Qual. Beats: 0
Rev. Trend: -46.6%
Qual. Beats: 1
Warnings
Interest Coverage Ratio 0.4 is critical
Volatile
Tailwinds
No distinct edge detected
Albemarle Corporation (ALB) operates in the specialty chemicals sector, providing materials for various industrial applications. The company is structured into three segments: Energy Storage, Specialties, and Ketjen.
The Energy Storage segment focuses on lithium compounds, essential for lithium-ion batteries used in electric vehicles and consumer electronics. This segments products also support power grids and solar panels, reflecting the growing demand for renewable energy infrastructure.
The Specialties segment offers a range of bromine and specialized lithium solutions. These include fire safety compounds and various bromine-based chemicals, serving industries such as energy, mobility, and health. This segment also provides niche products like cesium and zirconium for specific industrial applications, and offers recycling services for lithium by-products.
The Ketjen segment supplies clean fuels technologies, including hydroprocessing and catalytic cracking catalysts. These catalysts are crucial for refining petroleum and producing cleaner fuels, a key component of the conventional energy industry.
Albemarle serves diverse markets including automotive, aerospace, electronics, and pharmaceuticals. To continue your research on Albemarle and its competitors, consider exploring ValueRays detailed company profiles and sector analyses.
- Global EV demand dictates lithium sales
- Lithium prices directly impact Energy Storage segment revenue
- Regulatory scrutiny on mining practices increases operating costs
- Competition from new lithium producers pressures market share
- Energy transition policies boost demand for battery materials
| Net Income: -510.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 10.25 > 1.0 |
| NWC/Revenue: 42.98% < 20% (prev 34.88%; Δ 8.09% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.28b > Net Income -510.6m |
| Net Debt (1.68b) to EBITDA (749.7m): 2.24 < 3 |
| Current Ratio: 2.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (117.7m) vs 12m ago -0.02% < -2% |
| Gross Margin: 13.06% > 18% (prev 0.01%; Δ 1.30k% > 0.5%) |
| Asset Turnover: 31.18% > 50% (prev 32.38%; Δ -1.19% > 0%) |
| Interest Coverage Ratio: 0.43 > 6 (EBITDA TTM 749.7m / Interest Expense TTM 207.7m) |
| A: 0.13 (Total Current Assets 4.01b - Total Current Liabilities 1.80b) / Total Assets 16.37b |
| B: 0.28 (Retained Earnings 4.61b / Total Assets 16.37b) |
| C: 0.01 (EBIT TTM 89.1m / Avg Total Assets 16.49b) |
| D: 0.65 (Book Value of Equity 4.28b / Total Liabilities 6.59b) |
| Altman-Z'' Score: 2.52 = A |
| DSRI: 0.75 (Receivables 764.8m/1.07b, Revenue 5.14b/5.38b) |
| GMI: 0.08 (GM 13.06% / 1.11%) |
| AQI: 1.11 (AQ_t 0.22 / AQ_t-1 0.20) |
| SGI: 0.96 (Revenue 5.14b / 5.38b) |
| TATA: -0.11 (NI -510.6m - CFO 1.28b) / TA 16.37b) |
| Beneish M-Score: -4.14 (Cap -4..+1) = AAA |
Over the past week, the price has changed by -3.22%, over one month by +1.89%, over three months by +7.12% and over the past year by +190.02%.
- StrongBuy: 6
- Buy: 3
- Hold: 17
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 188.7 | 9.5% |
P/S = 4.0824
P/B = 2.8766
P/EG = 1.2905
Revenue TTM = 5.14b USD
EBIT TTM = 89.1m USD
EBITDA TTM = 749.7m USD
Long Term Debt = 3.12b USD (from longTermDebt, last quarter)
Short Term Debt = 74.1m USD (from shortTermDebt, last quarter)
Debt = 3.30b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.68b USD (from netDebt column, last quarter)
Enterprise Value = 22.67b USD (20.99b + Debt 3.30b - CCE 1.62b)
Interest Coverage Ratio = 0.43 (Ebit TTM 89.1m / Interest Expense TTM 207.7m)
EV/FCF = 32.74x (Enterprise Value 22.67b / FCF TTM 692.5m)
FCF Yield = 3.05% (FCF TTM 692.5m / Enterprise Value 22.67b)
FCF Margin = 13.46% (FCF TTM 692.5m / Revenue TTM 5.14b)
Net Margin = -9.93% (Net Income TTM -510.6m / Revenue TTM 5.14b)
Gross Margin = 13.06% ((Revenue TTM 5.14b - Cost of Revenue TTM 4.47b) / Revenue TTM)
Gross Margin QoQ = 14.20% (prev 8.99%)
Tobins Q-Ratio = 1.38 (Enterprise Value 22.67b / Total Assets 16.37b)
Interest Expense / Debt = 1.75% (Interest Expense 57.8m / Debt 3.30b)
Taxrate = 21.0% (US default 21%)
NOPAT = 70.4m (EBIT 89.1m * (1 - 21.00%))
Current Ratio = 2.23 (Total Current Assets 4.01b / Total Current Liabilities 1.80b)
Debt / Equity = 0.35 (Debt 3.30b / totalStockholderEquity, last quarter 9.53b)
Debt / EBITDA = 2.24 (Net Debt 1.68b / EBITDA 749.7m)
Debt / FCF = 2.42 (Net Debt 1.68b / FCF TTM 692.5m)
Total Stockholder Equity = 9.95b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.10% (Net Income -510.6m / Total Assets 16.37b)
RoE = -5.13% (Net Income TTM -510.6m / Total Stockholder Equity 9.95b)
RoCE = 0.68% (EBIT 89.1m / Capital Employed (Equity 9.95b + L.T.Debt 3.12b))
RoIC = 0.63% (NOPAT 70.4m / Invested Capital 11.21b)
WACC = 11.03% (E(20.99b)/V(24.29b) * Re(12.55%) + D(3.30b)/V(24.29b) * Rd(1.75%) * (1-Tc(0.21)))
Discount Rate = 12.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.15%
[DCF] Terminal Value 58.28% ; FCFF base≈692.5m ; Y1≈454.6m ; Y5≈207.9m
[DCF] Fair Price = 8.75 (EV 2.71b - Net Debt 1.68b = Equity 1.03b / Shares 117.9m; r=11.03% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -83.07 | EPS CAGR: -25.73% | SUE: -0.51 | # QB: 0
Revenue Correlation: -46.58 | Revenue CAGR: 6.50% | SUE: 0.99 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.93 | Chg7d=-0.135 | Chg30d=+0.161 | Revisions Net=+0 | Analysts=10
EPS current Year (2026-12-31): EPS=7.90 | Chg7d=+0.004 | Chg30d=+1.615 | Revisions Net=+4 | Growth EPS=+1100.5% | Growth Revenue=+6.1%
EPS next Year (2027-12-31): EPS=8.75 | Chg7d=+0.067 | Chg30d=+0.950 | Revisions Net=+2 | Growth EPS=+10.7% | Growth Revenue=+6.0%
[Analyst] Revisions Ratio: +0.00 (2 Up / 2 Down within 30d for Next Quarter)